Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
13.66
Dollar change
+0.18
Percentage change
1.34
%
IndexRUT P/E- EPS (ttm)-0.81 Insider Own54.94% Shs Outstand13.14M Perf Week-4.14%
Market Cap181.96M Forward P/E- EPS next Y- Insider Trans2.69% Shs Float5.92M Perf Month-5.27%
Income-10.50M PEG- EPS next Q- Inst Own9.47% Short Float7.95% Perf Quarter-5.27%
Sales0.00M P/S- EPS this Y- Inst Trans12.73% Short Ratio14.47 Perf Half Y-5.01%
Book/sh0.38 P/B36.04 EPS next Y- ROA-140.17% Short Interest0.47M Perf Year11.06%
Cash/sh0.44 P/C31.26 EPS next 5Y- ROE-151.72% 52W Range8.00 - 21.44 Perf YTD29.85%
Dividend Est.- P/FCF- EPS past 5Y-36.91% ROI-210.64% 52W High-36.29% Beta3.24
Dividend TTM- Quick Ratio6.91 Sales past 5Y0.00% Gross Margin- 52W Low70.75% ATR (14)0.88
Dividend Ex-Date- Current Ratio6.91 EPS Y/Y TTM-16.04% Oper. Margin- RSI (14)48.91 Volatility7.82% 6.83%
Employees7 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price38.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-9.08% Payout- Rel Volume0.68 Prev Close13.48
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsNov 11 Avg Volume32.53K Price13.66
SMA200.01% SMA50-0.37% SMA200-6.79% Trades Volume22,249 Change1.34%
Date Action Analyst Rating Change Price Target Change
Sep-01-21Initiated H.C. Wainwright Buy $78
Nov-26-24 06:00AM
Nov-18-24 06:00AM
Aug-01-24 06:00AM
Jun-26-24 07:33AM
Jun-17-24 09:00AM
06:00AM Loading…
Jun-14-24 06:00AM
May-20-24 09:53PM
Apr-15-24 10:53PM
Apr-10-24 03:30PM
Mar-13-24 06:00AM
Mar-12-24 06:00AM
Mar-07-24 09:00AM
Feb-27-24 06:00AM
Feb-22-24 06:00AM
Feb-14-24 06:00AM
06:00AM Loading…
Nov-21-23 06:00AM
Sep-13-23 05:02PM
Jul-26-23 01:12PM
Jul-18-23 06:53AM
May-10-23 06:32AM
May-09-23 06:40AM
May-08-23 06:41AM
May-05-23 06:58AM
May-04-23 06:29AM
May-03-23 06:46AM
May-02-23 06:46AM
May-01-23 06:45AM
Apr-28-23 07:04AM
Apr-27-23 06:47AM
Apr-26-23 06:26AM
07:03AM Loading…
Apr-20-23 07:03AM
Apr-19-23 06:53AM
Apr-17-23 06:54AM
Apr-14-23 06:37AM
Apr-13-23 06:52AM
Apr-12-23 07:07AM
Apr-11-23 06:58AM
Apr-10-23 06:44AM
Apr-07-23 07:44AM
Apr-06-23 10:37AM
07:20AM
Apr-05-23 06:11AM
Apr-04-23 07:08AM
Apr-03-23 06:48AM
Mar-31-23 06:36AM
Mar-30-23 06:36AM
Mar-29-23 06:32AM
Mar-28-23 06:46AM
Mar-24-23 06:42AM
Mar-23-23 07:01AM
Mar-21-23 06:23AM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 06:01AM
Feb-28-23 06:43AM
Feb-27-23 06:50AM
Feb-24-23 07:17AM
Feb-23-23 07:21AM
Feb-22-23 06:56AM
Feb-21-23 07:35AM
Feb-17-23 06:27AM
Feb-16-23 07:28AM
Feb-15-23 07:01AM
Feb-14-23 06:23AM
Feb-13-23 07:30AM
Feb-10-23 06:42AM
Feb-09-23 06:51AM
Feb-08-23 06:45AM
Feb-07-23 06:46AM
Feb-06-23 06:56AM
Feb-03-23 06:32AM
Feb-02-23 06:43AM
Feb-01-23 06:14AM
05:30AM
Jan-31-23 06:50AM
Jan-30-23 06:42AM
Jan-27-23 07:00AM
Jan-26-23 06:44AM
Jan-25-23 06:39AM
06:39AM
Jan-11-23 06:53AM
Jan-05-23 05:10AM
Jan-04-23 06:54AM
Dec-29-22 06:51AM
06:48AM
Dec-28-22 06:58AM
Dec-27-22 07:11AM
Dec-23-22 06:32AM
Dec-22-22 06:34AM
Dec-21-22 09:55AM
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson JayeVP Clinical Reg AffairsNov 21 '24Buy12.911,00012,910264,148Nov 25 06:03 AM
Patel SnehalCEO and CFOSep 26 '24Buy14.631,50021,9455,536,102Sep 30 06:04 AM
Thompson JayeVP Clinical Reg AffairsAug 12 '24Buy13.8580011,080263,148Sep 16 06:05 AM
Patel SnehalCEO and CFOAug 06 '24Buy13.812,00027,6205,534,602Aug 08 06:05 AM
Patel SnehalCEO and CFOAug 05 '24Buy13.185,50072,4905,532,602Aug 07 06:05 AM
Thompson JayeVP Clinical Reg AffairsAug 02 '24Buy15.151,00015,150262,348Aug 05 06:05 AM
Patel SnehalCEO and CFOJul 23 '24Buy15.891,50023,8355,527,102Jul 24 06:05 AM
Thompson JayeVP Clinical Reg AffairsJul 18 '24Buy16.001,00016,000261,348Jul 22 06:05 AM
Patel SnehalCEO and CFOJun 13 '24Buy14.30174,8252,499,9985,525,602Jun 17 06:10 AM
Patel SnehalCEO and CFOApr 01 '24Buy19.083,00057,2405,350,777Apr 03 06:10 AM
Patel SnehalCEO and CFOMar 22 '24Buy19.982,50049,9505,347,777Mar 26 06:05 AM
Patel SnehalCEO and CFOMar 20 '24Buy17.681,50026,5205,345,277Mar 22 06:02 AM
Patel SnehalCEO and CFOMar 05 '24Buy12.4930,500380,9455,343,777Mar 07 06:05 AM
Patel SnehalCEO and CFOMar 04 '24Buy13.034,10053,4235,340,277Mar 06 06:05 AM
Patel SnehalCEO and CFOFeb 16 '24Buy11.1610,800120,5285,336,177Feb 21 06:05 AM
Patel SnehalCEO and CFOFeb 15 '24Buy11.0712,700140,5895,325,377Feb 20 06:04 AM